From: Becker's GI & Endoscopy <editorial@beckershealthcare.com>
Subject: Top 10 states with highest volume of GI procedures | Valeant Pharmaceuticals rebrands as Bausch Health Companies amid transformation - 4 key points | New York Hospital reportedly pays CEO $660k to 'disappear'
Preheader:
Reply: editorial@beckershealthcare.com
View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ 
                                                    
May 9, 2018 
Today's Top Stories
1. Top 10 states with highest volume of GI procedures Full story

2. Valeant Pharmaceuticals rebrands as Bausch Health Companies amid transformation - 4 key points Full story 

3. New York Hospital reportedly pays CEO $660k to 'disappear' 
Full story

4. Patients want to contact physicians through apps and devices - are you ready? Learn how technology you may already have can make it happen Click here

5. Register today for the 16th Annual Future of Spine + Spine, Orthopedic & Pain Management-Driven ASC Conference in Chicago.

6. 5 most read GI/endoscopy stories of the week Full story 

7. GI leader to know: Dr. Christopher Brown of Atlanta Gastroenterology Associates Full story

8. Discover the importance of leveraging data on regional payer reimbursements Click here

9. FDA permits marketing of Hemospray to treat GI bleeding: 5 things to know Full story

10. gMed brings 2 more practices on board - 5 insights Full story

11. Is an HOPD to ASC conversion part of your value-based care strategy? A leader at the forefront of this trend shares guidelines for success. Click here

   
                                                        


              
Channels
_____________________
Contact Us

Editorial Contact: 
Laura Dyrda   
Editor in Chief  
(312) 253-9170
email Laura

Sales, Marketing & Events:
Jessica Cole
President and CEO
______________________
 
   
Becker's ASC Review
A Becker's Healthcare Publication
17 N. State, Suite 1800| Chicago, IL 60602